Published in J Clin Pathol on January 01, 1966
Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J (Clin Res Ed) (1981) 4.12
An automated method for the measurement of folate activity. J Clin Pathol (1970) 2.94
Lymphocytic infiltration of epithelium in diagnosis of gluten-sensitive enteropathy. Br Med J (1972) 2.11
Folate deficiency after anticonvulsant drugs: an effect of hepatic enzyme induction? Br Med J (1972) 1.95
Automation of the assay of folate in serum and whole blood. J Clin Pathol (1970) 1.90
Microbiological assay on microtitre plates of folate in serum and red cells. J Clin Pathol (1992) 1.73
Screening for abnormal haemoglobins: a pilot study. Br Med J (1973) 1.72
Folate state of premature infants. Arch Dis Child (1969) 1.67
Vitamin B12 absorption after resection of ileum in childhood. Arch Dis Child (1974) 1.47
Diagnostic value of the serum folate assay. J Clin Pathol (1971) 1.40
Folate deficiency in Crohn's disease: incidence, pathogenesis, and treatment. Br Med J (1968) 1.34
Iron and folate metabolism in tuberculosis. Br Med J (1966) 1.33
Response of low birthweight infant to treatment with folic acid. Arch Dis Child (1971) 1.30
Coeliac disease during the teenage period: the value of serial serum folate estimations. Gut (1974) 1.26
Estimation of red cell folate activity. J Clin Pathol (1969) 1.16
Assessment of the value of a competitive protein binding radioassay of folic acid in the detection of folic acid deficiency. J Clin Pathol (1984) 1.05
Measurement of serum folate: experience with 75Se-selenofolate radioassay. J Clin Pathol (1977) 1.05
A haematological study of patients receiving long-term treatment with trimethoprim and sulphonamide. J Clin Pathol (1970) 1.02
Screening of psychiatric patients for hypovitaminosis B12. Br Med J (1969) 1.00
Lower risk of cervical intraepithelial neoplasia in women with high plasma folate and sufficient vitamin B12 in the post-folic acid fortification era. Cancer Prev Res (Phila) (2009) 0.99
Folate binders in body fluids. J Clin Pathol (1970) 0.94
Vitamin B 12 status in pregnancy among immigrants to Britain. Br Med J (1973) 0.91
Folate metabolism in epileptic and psychiatric patients. J Neurol Neurosurg Psychiatry (1971) 0.90
Nutrition in cryptogenic cirrhosis and chronic aggressive hepatitis. Gut (1976) 0.89
Serum folate and vitamin B12 levels in acute and chronic renal disease. Effect of peritoneal dialysis. Br Med J (1969) 0.89
Influence of folic acid on birthweight and growth of the erythroblastotic infant. II. Growth during the first year. Arch Dis Child (1977) 0.88
Nutrient intake values for folate during pregnancy and lactation vary widely around the world. Nutrients (2013) 0.85
Factors influencing the release of assayable folate from erythrocytes. J Clin Pathol (1969) 0.85
Problems in the diagnosis and investigation of megaloblastic anemia. Can Med Assoc J (1980) 0.85
Incidence and pathogenesis of megaloblastic erythropoiesis in multiple myeloma. J Clin Pathol (1967) 0.84
The laboratory diagnosis of megaloblastic anemias. West J Med (1978) 0.80
Clinical significance of a high mean corpuscular volume in nonanemic patients. Can Med Assoc J (1977) 0.80
Ordering folate assays is no longer justified for investigation of anemias, in folic acid fortified countries. BMC Res Notes (2010) 0.80
Plasma and erythrocyte folate concentrations in normal mature infants. Arch Dis Child (1973) 0.79
Endemic tropical sprue in Rhodesia. Gut (1976) 0.79
Folate supplements during pregnancy. J R Coll Gen Pract (1976) 0.78
Anemia of Central Origin. Semin Hematol (2015) 0.76
Serum and red cell folates, and serum vitamin B 12 in protein calorie malnutrition. Arch Dis Child (1973) 0.75
Nature of anaemia in rheumatoid arthritis. X. Folate-releasing properties of plasma in health and disease, with special reference to rheumatoid arthritis. Ann Rheum Dis (1969) 0.75
Significance of subnormal red-cell folate in thalassaemia. J Clin Pathol (1976) 0.75
A pteroylpolyglutamate binds to tetramers in deoxyhemoglobin but to dimers in oxyhemoglobin. Proc Natl Acad Sci U S A (1983) 0.75
Measurement of red cell folate with 75Se-selenofolate radioassay. J Clin Pathol (1978) 0.75
Haemoglobin A2 levels in vitamin B12 and folate deficiency. J Clin Pathol (1978) 0.75
Absorption of xylose, glucose, glycine, and folic (pteroylglutamic) acid in Zambian Africans with anaemia. Gut (1976) 0.75
Coeliac disease. Reappraisal of clinical diagnosis. Arch Dis Child (1971) 0.75
Comparative and serial assays of folate metabolism in anticonvulsant-treated epileptics. J Clin Pathol (1972) 0.75
Studies on the folic acid activity of human serum. J Clin Pathol (1961) 11.42
A microbiologic method for detecting folic acid deficiency in man. Clin Chem (1959) 4.62
Conventional voltage electrophoresis for formiminoglutamic-acid determination in folic acid deficiency. J Clin Pathol (1961) 4.14
DETERMINATION OF DENSITY DISTRIBUTION OF RED CELL POPULATION. J Lab Clin Med (1964) 3.67
The measurement of folic acid activity in serum: a diagnostic aid in the differentiation of the megaloblastic anemias. Blood (1960) 3.48
INVESTIGATIONS INTO THE EUGLENA METHOD FOR THE ASSAY OF THE VITAMIN B12 IN SERUM. J Clin Pathol (1964) 3.09
Interrelations of vitamin B12 and folic acid metabolism: folic acid clearance studies. J Clin Invest (1962) 2.86
Precursors of the folic acid-active factors of blood. J Biol Chem (1956) 2.45
Influence of succinylsulfathiazole and folic acid on glutamic acid excretion. J Biol Chem (1951) 2.30
Microbiologic determination of folic acid derivatives in blood. Blood (1962) 1.98
Folic and folinic acid in maternal and foetal blood. Br J Haematol (1960) 1.79
Histidine metabolic loading test to distinguish folic acid deficiency from vit. B12 in megaloblastic anemias. Proc Soc Exp Biol Med (1959) 1.68
Metabolic effects and diagnostic value of small doses of folic acid and B12 in megaloblastic anemias. Acta Med Scand (1962) 1.56
Formiminoglutamic acid (FIGLU) excretion in hepatic cirrhosis. Arch Intern Med (1961) 1.52
SOME INVESTIGATIONS OF FOLIC-ACID DEFICIENCY. Scott Med J (1964) 1.48
Evaluation of assessment of folic-acid deficiency by serum folic-acid activity measured with L. casei. Can Med Assoc J (1961) 1.29
Urocanic acid and formimino-glutamic acid excretion in megaloblastic anaemia and other conditions: the effect of specific therapy. Br J Haematol (1963) 1.17
Blood folic acid activity of normal humans, cancer patients, and noncancer patients; with a few observations on animals. Cancer (1957) 1.15
Abnormal folic acid metabolism in vitamin B12 deficiency. Clin Sci (1962) 1.07
Detection and isolation of formiminoglutamic acid from urine in folic acid deficiency in humans. Proc Soc Exp Biol Med (1959) 1.06
FOLIC ACID ACTIVITY IN SERUM AND RED CELLS IN PATIENTS WITH VITAMIN B12 DEFICIENCY: RELATION TO TREATMENT. Br J Haematol (1965) 0.92
THE EFFECT OF SMALL DOSES OF FOLIC ACID IN NUTRITIONAL MEGALOBLASTIC ANEMIA. Am J Clin Nutr (1963) 0.91
A study of proximal and distal intestinal structure and absorptive function in idiopathic steatorrhoea. Q J Med (1967) 4.68
Tissue antibodies in dermatitis herpetiformis and adult coeliac disease. Lancet (1971) 3.50
Small-intestinal structure and function and haematological changes in dermatitis herpetiformis. Lancet (1967) 3.11
Circulating immune complexes in dermatitis herpetiformis. Lancet (1973) 2.78
Anti-reticulin antibodies in childhood coeliac disease. Lancet (1971) 2.54
Efficacy and possible adverse effects of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in thalassemia major. Blood (1992) 2.29
Folic acid fortification and cancer risk. Lancet (2007) 2.17
Antireticulin antibody: incidence and diagnostic significance. Gut (1973) 2.15
Lymphocytic infiltration of epithelium in diagnosis of gluten-sensitive enteropathy. Br Med J (1972) 2.11
Effect of gluten-free diet on dermatological, intestinal, and haematological manifestations of dermatitis herpetiformis. Lancet (1968) 2.09
Clearance of skin lesions in dermatitis herpetiformis after gluten withdrawal. Lancet (1973) 2.01
Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients. Lancet (1982) 2.01
Parenteral acyclovir therapy for herpesvirus infections in man. Lancet (1979) 1.99
Effects of intrahepatic and extrahepatic infection on liver function. Br Med J (1966) 1.98
The human thymic microenvironment: an immunohistologic study. J Immunol (1980) 1.94
Recurrent thrombocytopenia, erythroid hypoplasia and sideroblastic anaemia associated with hypothermia. Br J Haematol (1982) 1.93
Combined therapy with deferiprone and desferrioxamine. Br J Haematol (1998) 1.91
Agranulocytosis and thrombocytopenia in patient with Blackfan-Diamond anaemia during oral chelator trial. Lancet (1989) 1.91
Assessment and significance of bacterial overgrowth in the small bowel. Q J Med (1970) 1.89
Megaloblastic haemopoiesis in patients receiving nitrous oxide. Lancet (1978) 1.85
Folate deficiency and neurological disease. Lancet (1965) 1.85
Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br J Haematol (1996) 1.82
Subcutaneous infusion and intramuscular injection of desferrioxamine in patients with transfusional iron overload. Lancet (1976) 1.81
Hypoparathyroidism and hypocalcaemia during treatment for acute leukaemia. Br Med J (Clin Res Ed) (1982) 1.72
Improvement in iron status and liver function in patients with transfusional iron overload with long-term subcutaneous desferrioxamine. Lancet (1979) 1.70
Serum ferritin assay and iron status in chronic renal failure and haemodialysis. Br Med J (1975) 1.61
Gluten-free diet and reintroduction of gluten in dermatitis herpetiformis. Arch Dermatol (1969) 1.60
Deletion analysis of chromosome 13q14.3 and characterisation of an alternative splice form of LEU1 in B cell chronic lymphocytic leukemia. Leukemia (2002) 1.60
Bone-marrow aspiration and trephine biopsy (1). Br Med J (1980) 1.58
Mechanism of folate deficiency in patients receiving phenytoin. Lancet (1968) 1.58
Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia. Lancet (1982) 1.55
The hematologic complications following partial gastrectomy. A study of 292 patients. Am J Med (1967) 1.55
The small intestine in dermatitis herpetiformis. J Clin Pathol (1974) 1.54
Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol (2000) 1.54
Immunoglobulins in the skin in dermatitis herpetiformis and coeliac disease. Lancet (1972) 1.53
Unusual megaloblastic anaemia wiht multinucleate erythroblasts: two cases with septicaemia and acute renal failure. J Clin Pathol (1975) 1.53
Subpopulations of normal and leukemic human thymocytes: an analysis with the use of monoclonal antibodies. J Natl Cancer Inst (1980) 1.50
Protein malnutrition after partial gastrectomy. Q J Med (1967) 1.47
Increased numbers of cells with suppressor T cell phenotype in the peripheral blood of patients with infectious mononucleosis. Clin Exp Immunol (1981) 1.45
Multiple immune complexes and hypocomplementaemia in dermatitis herpetiformis and coeliac disease. Lancet (1976) 1.45
Iron chelation therapy: the need for orally active drugs. J Lab Clin Med (1998) 1.42
Serum immunoreactive trypsin in beta-thalassaemia major. J Clin Pathol (1981) 1.41
Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue. J Immunol (1985) 1.41
Stomatococcus mucilaginosus: an emerging pathogen in neutropenic patients. Clin Infect Dis (1992) 1.39
Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial. Br Med J (Clin Res Ed) (1983) 1.37
Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet (1988) 1.35
Absorption of crystalline folic acid in man. Lancet (1968) 1.35
Folate deficiency in Crohn's disease: incidence, pathogenesis, and treatment. Br Med J (1968) 1.34
Multiparameter studies in lymphoid leukemias. Am J Clin Pathol (1979) 1.34
Iron and folate metabolism in tuberculosis. Br Med J (1966) 1.33
Folate deficiency in premature infants. Arch Dis Child (1970) 1.33
Orally active alpha-ketohydroxy pyridine iron chelators intended for clinical use: in vivo studies in rabbits. Br J Haematol (1986) 1.31
High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation. Acta Haematol (1990) 1.30
Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells. Br J Haematol (1976) 1.30
Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow. Lancet (1986) 1.29
Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemia. Lancet (1980) 1.29
Streptococcus mitis and ARDS in neutropenic patients. Lancet (1991) 1.28
Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one. Br Med J (Clin Res Ed) (1987) 1.28
Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside. Br J Haematol (1974) 1.28
Splenic atrophy in dermatitis herpetiformis. Br Med J (1972) 1.25
Studies of folate uptake by phytohaemagglutinin-stimulated lymphocytes. Br J Haematol (1970) 1.25
Comparison of three methods for measuring vitamin B 12 in serum: radioisotopic, euglena gracilis and Lactobacillus leichmannii. Br J Haematol (1972) 1.23
Indices of granulocyte activity in inflammatory bowel disease. Gut (1974) 1.21
Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J Exp Med (1993) 1.20
Alternate-pathway complement fixation by IgA in the skin in dermatitis herpetiformis. Lancet (1973) 1.20
Possible association between pernicious anaemia and leukaemia: a prospective study of 1,625 patients with a note on the very high incidence of stomach cancer. Int J Cancer (1968) 1.20
The use of chicken serum for measurement of serum vitamin B12 concentration by radioisotope dilution: discription of method and comparison with microbiological assay results. Br J Haematol (1974) 1.20
Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. Clin Infect Dis (1993) 1.19
1,2-Dimethyl-3-hydroxypyrid-4-one, an orally active chelator for treatment of iron overload. Lancet (1987) 1.19
Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine. J Clin Pathol (1987) 1.17
The serum vitamin B12 level: its assay and significance. Clin Haematol (1976) 1.17
High prevalence of low bone mass in thalassaemia major. Br J Haematol (1998) 1.15
Development of pluripotent hematopoietic progenitor cells in the human fetus. Blood (1983) 1.15
Effect of serum-factors other than folate on the Lactobacillus casei assay. Lancet (1966) 1.14
Inherited lack of transcobalamin II in serum and megaloblastic anaemia: a further patient. Br J Haematol (1979) 1.14
Effect of ascorbic acid deficiency on serum ferritin concentration in patients with beta-thalassaemia major and iron overload. J Clin Pathol (1982) 1.14
Absorption of vitamin B 12 by the guinea-pig. I. Subcellular localization of vitamin B 12 in the ileal enterocyte during absorption. Br J Haematol (1970) 1.13
Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis. Br J Haematol (1999) 1.13
Heavy metal intoxication from homeopathic and herbal remedies. Postgrad Med J (1994) 1.12
The effect of deoxyuridine, vitamin B12, folate and alcohol on the uptake of thymidine and on the deoxynucleoside triphosphate concentrations in normal and megaloblastic cells. Br J Haematol (1978) 1.12
Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A. Lancet (1981) 1.11
The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients. Haematologica (2001) 1.10
The effect of external deoxyribonucleosides on deoxyribonucleoside triphosphate concentrations in human lymphocytes. Biochem Pharmacol (1975) 1.10
Effect of dose, time, and ascorbate on iron excretion after subcutaneous desferrioxamine. Lancet (1977) 1.08
The excretion of foriminoglutamic acid and urocanic acid after partial gastrectomy. Lancet (1966) 1.07
The subcellular localization of pteroyl polyglutamate hydrolase and folate in guinea pig intestinal mucosa. Biochim Biophys Acta (1969) 1.07
Pharmacokinetics of the oral iron chelator deferiprone (L1) in patients with iron overload. Br J Haematol (1995) 1.07
Chaetomium pneumonia in patient with acute myeloid leukaemia. J Clin Pathol (1996) 1.07
Serum lysozyme and vitamin B 12 binding capacity in myeloproliferative disorders. Br J Haematol (1971) 1.06
Anaemia in adult coeliac disease. Clin Gastroenterol (1974) 1.06
Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosis. Dig Dis Sci (1982) 1.04
Infection with Yersinia enterocolitica in patients with iron overload. Br Med J (Clin Res Ed) (1986) 1.04
The effect of vitamin B12 deficiency on methylfolate metabolism and pteroylpolyglutamate synthesis in human cells. Clin Sci Mol Med (1974) 1.04
The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro. Leukemia (2006) 1.04